Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products, surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices. Co. manages its global operations based on four segments, consisting of the following geographic segments: North and South America, Europe, Middle East and Africa, and Asia-Pacific, and a global segment for its Hill-Rom Holdings, Inc. business.
Baxter International SEC Filing Email Alerts Service
Baxter International SEC Filing Email Alerts Service
|
|
Free BAX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.67 out of 4) 12nd percentile
(ranked lower than approx. 88% of all stocks covered)
Analysts' Target Price: BAX Stock Forecast Based on Zacks ABR data; powered by Xignite |